Parkside Investments LLC Purchases 2,050 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Parkside Investments LLC raised its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 123,507 shares of the exchange traded fund’s stock after acquiring an additional 2,050 shares during the period. SPDR S&P Biotech ETF makes up 1.7% of Parkside Investments LLC’s portfolio, making the stock its 18th biggest holding. Parkside Investments LLC owned approximately 0.16% of SPDR S&P Biotech ETF worth $11,123,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in XBI. FMR LLC boosted its stake in SPDR S&P Biotech ETF by 13.6% during the 3rd quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock valued at $686,000 after purchasing an additional 830 shares during the period. Ameritas Advisory Services LLC boosted its holdings in SPDR S&P Biotech ETF by 11.9% in the 4th quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock valued at $962,000 after purchasing an additional 1,137 shares during the period. Beaton Management Co. Inc. acquired a new stake in SPDR S&P Biotech ETF in the 3rd quarter worth $212,000. Robinson Value Management Ltd. increased its holdings in shares of SPDR S&P Biotech ETF by 1.2% during the 3rd quarter. Robinson Value Management Ltd. now owns 13,452 shares of the exchange traded fund’s stock worth $1,329,000 after purchasing an additional 155 shares during the period. Finally, Granite Bay Wealth Management LLC raised its position in shares of SPDR S&P Biotech ETF by 4,965.8% during the second quarter. Granite Bay Wealth Management LLC now owns 124,062 shares of the exchange traded fund’s stock valued at $11,097,000 after buying an additional 121,613 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 0.6 %

XBI stock opened at $92.46 on Monday. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The company has a market cap of $7.05 billion, a PE ratio of 11.47 and a beta of 1.11. The business’s 50-day simple moving average is $93.34 and its 200 day simple moving average is $96.90.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.